Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Histamine Receptor 2 Antagonists as Enhancers of Anti-Tumour Immunity

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03145012
Recruitment Status : Unknown
Verified March 2019 by Lisa Barrett, Nova Scotia Health Authority.
Recruitment status was:  Active, not recruiting
First Posted : May 9, 2017
Last Update Posted : March 11, 2019
Sponsor:
Collaborators:
Nova Scotia Health Authority
Dalhousie University
Information provided by (Responsible Party):
Lisa Barrett, Nova Scotia Health Authority

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : November 1, 2019
Estimated Study Completion Date : November 1, 2019